Document Detail


Neutrophil Proteinase 3 Induces Diabetes in a Mouse Model of Glucose Tolerance.
MedLine Citation:
PMID:  22014109     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Type 1 diabetes is considered to be an autoimmune disease in which T cells attack pancreatic islet cells. Impaired glucose tolerance with type 2 diabetes has been classified as an obesity-associated metabolic syndrome. However, recent studies have revealed that type 2 diabetes is an autoinflammatory disease due to an imbalance of inflammatory cytokine production and related molecular components that cause inflammation. Insulin-like growth factor (IGF) and the insulin-like growth factor-binding protein-3 (IGFBP3) system are known to be involved in the development of experimental diabetic nephropathy, and urinary IGFBP3 protease activity has been observed in patients with type 2 diabetes. A serine protease was found to be responsible for the proteolytic activity in diabetic urine; however, the identity of the precise enzyme remains unknown. We investigated neutrophil proteinase 3 (PR3) to see whether it has specific enzymatic activity associated with insulin-like growth factor-1 and IGFBP3. In our study, both molecules were sufficiently degraded, which leads us to believe that PR3 may induce insulin resistance in the mouse model utilized. In addition, we found that PR3 in the urine of diabetic patients similarly affects insulin resistance. Moreover, PR3-immunized mice had an increase in glucose clearance due to inhibition of PR3 activity. As such, PR3 can be considered as an inflammatory enzyme directly linking inflammation to type 2 diabetes through downregulation of insulin-like growth factor-1/IGFBP3.
Authors:
Suyoung Bae; Jida Choi; Jaewoo Hong; Hyunjhung Jhun; Kwangwon Hong; Taebong Kang; Keeho Song; Sangmin Jeong; Hokee Yum; Soohyun Kim
Related Documents :
8260199 - Could non-insulin-dependent diabetes mellitus be attributable to a deficiency of fad-li...
21688249 - Inhibitors of vascular calcification as potential therapeutic targets.
21205109 - Liraglutide - overview of the preclinical and clinical data and its role in the treatme...
3929599 - Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabe...
1111399 - The early detection of airway obstruction.
21431099 - Alogliptin for the treatment of type 2 diabetes.
16598319 - Effects of vitamin e and gemfibrozil on lipid profiles, lipid peroxidation and antioxid...
9406199 - The metabolic properties of spermatozoa from the epididymis of the tammar wallaby, macr...
7476339 - Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-20
Journal Detail:
Title:  Endocrine research     Volume:  -     ISSN:  1532-4206     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8408548     Medline TA:  Endocr Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Laboratory of Cytokine Immunology, Institute of Biomedical Science and Technology, College of Medicine, Konkuk University , Seoul , Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Critical Approach to the Thermodynamic Characterization of Inclusion Complexes: Multiple-Temperatu...
Next Document:  Use of mycelia as paths for the isolation of contaminant-degrading bacteria from soil.